Login / Signup

A 2-year review of publicly funded cell-free DNA screening in Ontario: utilization and adherence to funding criteria.

Kara Bellai-DussaultLynn MengTianhua HuangJessica ReszelMark WalkerAndrea LanesNan OkunChristine ArmourShelley Dougan
Published in: Prenatal diagnosis (2019)
Reviewing and auditing the application of criteria for funded cfDNA screening using prescribed registry data allows an opportunity to identify areas where targeted education may improve adherence to standardized screening protocols, and provides a basis for reassessment of the funding model.
Keyphrases
  • healthcare
  • type diabetes
  • metabolic syndrome
  • cancer therapy
  • big data
  • quality improvement
  • adipose tissue
  • skeletal muscle
  • weight loss